Lactoferricin B-derived peptides with inhibitory effects on ECE-dependent vasoconstriction

Peptides

Volumn 31, Issue 10, 2010, Pages 1926-1933

  Fernández Musoles, Ricardo ^a   López Díez, José Javier ^a   Torregrosa, Germán ^b,c   Vallés, Salvador ^a   Alborch, Enrique ^b,c   Manzanares, Paloma ^a   Salom, Juan B ^b,c  

^a INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Bioactive peptide; Endothelin system; Endothelin converting enzyme; Hypertension; Lactoferricin B derived peptide; Vascular tone; Vasopeptidase inhibitor

Indexed keywords

AC ARGINYLARGINYLTRYPTOPHYLGLUTAMINYLTRYPTOPHYLARGININE NH2; AC CYSTEINYLARGINYLARGINYLTRYPTOPHYLGLUTAMINYLTRYPTOPHYLARGININE NH2; AC LYSYLCYSTEINYLARGINYLARGINYLTRYPTOPHYLGLUTAMINYLTRYPTOPHYLARGININE NH2; AC PHENYLALANYLLYSYLCYSTEINYLARGINYLARGINYLTRYPTOPHAN NH2; AC PHENYLALANYLLYSYLCYSTEINYLARGINYLARGINYLTRYPTOPHYLGLUTAMINYLTRYPTOPHAN NH2; AC PHENYLALANYLLYSYLCYSTEINYLARGINYLARGINYLTRYPTOPHYLGLUTAMINYLTRYPTOPHYLARGININE NH2; AC PHENYLALANYLLYSYLCYSTEINYLARGINYLARGINYLTRYPTOPHYLGLUTAMINYLTRYPTOPHYLARGINYLMETHIONYLLYSYLLYSYLLEUCYLGLYCYLALANINE NH2; AC PHENYLALANYLLYSYLCYSTEINYLARGINYLARGINYLTRYPTOPHYLGLUTAMINYLTRYPTOPHYLARGINYLMETHIONYLLYSYLLYSYLLEUCYLGLYCYLALANYLPROLINE NH2; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN CONVERTING ENZYME; FLUOROGENIC PEPTIDE SUBSTRATE V; LACTOFERRICIN B; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; EX VIVO STUDY; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SIGNAL TRANSDUCTION; VASOCONSTRICTION;

ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; ENDOTHELIN-1; HUMANS; HYPERTENSION; LACTOFERRIN; MALE; METALLOENDOPEPTIDASES; PEPTIDES; RABBITS; RECEPTOR, ENDOTHELIN A; SIGNAL TRANSDUCTION; VASOCONSTRICTION;

ORYCTOLAGUS CUNICULUS;

EID: 77956667171     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.06.024     Document Type: Article

References (42)

1. B. Battistini, B. Ayach, S. Molez, A. Blouin, and A.Y. Jeng Effects of benazepril, an angiotensin-converting enzyme inhibitor, combined with CGS 35066, a selective endothelin-converting enzyme inhibitor, on arterial blood pressure in normotensive and spontaneously hypertensive rats Clin Sci (Lond) 103 Suppl. 48 2002 363S 366S
2. B. Battistini, P. Daull, and A.Y. Jeng CGS 35601, a triple inhibitor of angiotensin converting enzyme, neutral endopeptidase and endothelin converting enzyme Cardiovasc Drug Rev 23 2005 317 330
3. R.M. Carey, and H.M. Siragy Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation Endocr Rev 24 2003 261 271
4. J.M. Centeno, M.C. Burguete, M. Castelló-Ruiz, M. Enrique, S. Vallés, and J.B. Salom Lactoferricin-related peptides with inhibitory effects on ACE-dependent vasoconstriction J Agric Food Chem 54 2006 5323 5329
5. T.L. Chen, Y.C. Lo, W.T. Hu, M.C. Wu, S.T. Chen, and H.M. Chang Microencapsulation and modification of synthetic peptides of food proteins reduces the blood pressure of spontaneously hypertensive rats J Agric Food Chem 51 2003 1671 1675
6. H.S. Cheung, F.L. Wang, M.A. Ondetti, E.F. Sabo, and D.W. Cushman Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence J Biol Chem 255 1980 401 407
7. F. De Leo, S. Panarese, R. Gallerani, and L.R. Ceci Angiotensin converting enzyme (ACE) inhibitory peptides: production and implementation of functional food Curr Pharm Des 15 2009 3622 3643
8. J.L. Gifford, H.N. Hunter, and H.J. Vogel Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties Cell Mol Life Sci 62 2005 2588 2598
9. T.D. Giles, B.J. Materson, J.N. Cohn, and J.B. Kostis Definition and classification of hypertension: an update J Clin Hypertens (Greenwich) 11 2009 611 614
10. N.H. Gokhale, and J.A. Cowan Metallopeptide-promoted inactivation of angiotensin-converting enzyme and endothelin-converting enzyme 1: toward dual-action therapeutics J Biol Inorg Chem 11 2006 937 947
11. I. Hajjar, and T.A. Kotchen Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000 JAMA 290 2003 199 206
12. T.W. Hein, Y. Ren, Z. Yuan, W. Xu, S. Somvanshi, and T. Nagaoka Functional and molecular characterization of the endothelin system in retinal arterioles Invest Ophthalmol Vis Sci 50 2009 3329 3336
13. R. Ikegawa, Y. Matsumura, Y. Tsukahara, M. Takaoka, and S. Morimoto Phosphoramidon, a metalloproteinase inhibitor, suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting a big endothelin-1 converting enzyme Biochem Biophys Res Commun 171 1990 669 675
14. G.D. Johnson, and K. Ahn Development of an internally quenched fluorescent substrate selective for endothelin-converting enzyme-1 Anal Biochem 286 2000 112 118
15. P.M. Kearney, M. Whelton, K. Reynolds, P. Muntner, P.K. Whelton, and J. He Global burden of hypertension: analysis of worldwide data Lancet 365 2005 217 223
16. R.M. Kedzierski, and M. Yanagisawa Endothelin system: the double-edged sword in health and disease Annu Rev Pharmacol Toxicol 41 2001 851 876
17. K. Kouno, S. Hirano, H. Kuboki, M. Kasai, and K. Hatae Effects of dried bonito (katsuobushi) and captopril, an angiotensin I-converting enzyme inhibitor, on rat isolated aorta: a possible mechanism of antihypertensive action Biosci Biotechnol Biochem 69 2005 911 915
18. N.Y. Lee, J.T. Cheng, T. Enomoto, and I. Nakamura The antihypertensive activity of angiotensin-converting enzyme inhibitory peptide containing in bovine lactoferrin Chin J Physiol 49 2006 67 73
19. S. Lindenau, C. von Langsdorff, A. Saxena, M. Paul, and H.D. Orzechowski Genomic organisation of the mouse gene encoding endothelin-converting enzyme-1 (ECE-1) and mRNA expression of ECE-1 isoforms in murine tissues Gene 373 2006 109 115
20. B receptors and endothelial modulators in diabetes-induced hyperreactivity of the rabbit carotid artery to endothelin-1 Eur J Pharmacol 486 2004 43 51
21. R. López-Fandiño, J. Otte, and J. van Camp Physiological, chemical and technological aspects of milk-protein-derived peptides with antihypertensive and ACE-inhibitory activity Int Dairy J 16 2006 1277 1293
22. W. Maes, J. Van Camp, V. Vermeirssen, M. Hemeryck, J.M. Ketelslegers, and J. Schrezenmeir Influence of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg (ALPMHIR) on the release of endothelin-1 by endothelial cells Regul Pept 118 2004 105 109
23. M. Miguel, M.J. Alonso, M. Salaices, A. Aleixandre, and R. López-Fandiño Antihypertensive, ACE-inhibitory and vasodilator properties of an egg white hydrolysate: effect of a simulated intestinal digestion Food Chem 104 2007 163 168
24. M. Okitsu, A. Morita, M. Kakitani, M. Okada, and H. Yokogoshi Inhibition of the endothelin-converting enzyme by pepsin digests of food proteins Biosci Biotechnol Biochem 59 1995 325 326
25. J. Otte, S.M. Shalaby, M. Zakora, A.H. Pripp, and S.H. El-Shabrawy Angiotensin-converting enzyme inhibitory activity of milk protein hydrolysates: effect of substrate, enzyme and time of hydrolysis Int Dairy J 17 2007 488 503
26. A. Pihlanto-Leppälä Bioactive peptides derived from bovine whey proteins: opioid and ACE-inhibitory peptides Trends Food Sci Technol 11 2001 347 356
27. D.M. Pollock Endothelin, angiotensin, and oxidative stress in hypertension Hypertension 45 2005 477 480
28. V.S. Prasad, C. Palaniswamy, and W.H. Frishman Endothelin as a clinical target in the treatment of systemic hypertension Cardiol Rev 17 2009 181 191
29. I. Ricci, R. Artacho, and M. Olalla Milk protein peptides with angiotensin I-converting enzyme inhibitory (ACEI) activity Crit Rev Food Sci Nutr 50 2010 390 402
30. P. Ruiz-Giménez, M.C. Burguete, M. Castelló-Ruiz, J.F. Marcos, J.B. Salom, and S. Vallés Bovine lactoferrin pepsin hydrolysate exerts inhibitory effect on ACE-dependent vasoconstriction Int Dairy J 17 2007 1212 1215
31. P. Ruiz-Giménez, A. Ibáñez, J.B. Salom, J.F. Marcos, J.J. López-Díez, and S. Vallés Antihypertensive properties of lactoferricin B-derived peptides J Agric Food Chem 58 2010 6721 6727
32. E.L. Schiffrin Vascular endothelin in hypertension Vascul Pharmacol 43 2005 19 29
33. H. Schulz, G.E. Dale, Y. Karimi-Nejad, and C. Oefner Structure of human endothelin-converting enzyme I complexed with phosphoramidon J Mol Biol 385 2009 178 187
34. A. Schweizer, O. Valdenaire, P. Nelböck, U. Deuschle, J.B. Dumas Milne Edwards, and J.G. Stumpf Human endothelin-converting enzyme (ECE-1): three isoforms with distinct subcellular localizations Biochem J 328 Pt 3 1997 871 877
35. C.R. Tirapelli, M.H. Fecteau, J.C. Honore, E. Legros, F. Gobeil, and P. D'Orleans-Juste Enzymatic pathways involved in the generation of endothelin-1(1-31) from exogenous big endothelin-1 in the rabbit aorta Br J Pharmacol 148 2006 527 535
36. A.J. Trapani, M.E. Beil, C.W. Bruseo, S. De Lombaert, and A.Y. Jeng Pharmacological properties of CGS 35066, a potent and selective endothelin-converting enzyme inhibitor, in conscious rats J Cardiovasc Pharmacol 36 Suppl. 1 2000 S40 S43
37. O. Valdenaire, D. Lepailleur-Enouf, G. Egidy, A. Thouard, A. Barret, and R. Vranckx A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from an additional promoter molecular cloning and characterization Eur J Biochem 264 1999 341 349
38. H. Wakabayashi, K. Yamauchi, and M. Takase Lactoferrin research, technology and applications Int Dairy J 16 2006 1241 1251
39. B. Williams The changing face of hypertension treatment: treatment strategies from the 2007 ESH/ESC hypertension Guidelines J Hypertens 27 Suppl 3 2009 S19 S26
40. 1 receptor Peptides 31 2010 909 914
41. 2-dependent vasorelaxation in spontaneously hypertensive rats Peptides 29 2008 345 349
42. M. Zimmermann, C.S. Jung, H. Vatter, A. Raabe, and V. Seifert Effect of endothelin-converting enzyme inhibitors on big endothelin-1 induced contraction in isolated rat basilar artery Acta Neurochir (Wien) 144 2002 1213 1219